The pneumococcal infections drug pipeline includes next-gen conjugate vaccines, novel antibiotics, and monoclonal antibodies aimed at preventing resistant and invasive pneumococcal diseases. https://www.linkedin.com/pulse/pneumococcal-infections-drug-pipeline-analysis-market-choudhary-dhflf/